“Leaving so soon, Dr. Brill?”
It happened on a Tuesday.
Barbie set down the cup. “Dr. Voss, are you threatening me?” barbie brill lab rat
She’d been cross-referencing old animal studies from before her time at Brill. Buried in a corrupted file folder labeled “Archived_Env_Data,” she found something odd: a subdirectory of histological slides from rhesus macaques dosed with Compound 7-K’s precursor, 7-A. The slides showed massive glial scarring in the hippocampus. Not neurodegeneration—something worse. Rewiring. “Leaving so soon, Dr
Barbie zoomed in on the timestamp metadata. The study wasn’t five years old, as the folder claimed. It was from last March. And the principal investigator’s code was VOSS. The slides showed massive glial scarring in the hippocampus
Even Dr. Lorne Voss, the Nobel-hyped director of the Brill Lab’s neuro-pharmacology division, had made that mistake exactly once.
She looked at the NDA. Buried on page 27 was a clause: Employee agrees to destroy any and all data related to Compound 7-series research prior to January of this year.